Industry, FDA Start To Settle Into 510(k) Refuse-To-Accept Program
This article was originally published in The Gray Sheet
Executive Summary
After a rocky start, the rate of 510(k)s being turned away by FDA before full review under the refuse-to-accept program has steadily declined, and industry expects continued improvement.